- Home
- DERM vs JLS Comparison
DERM vs JLS Comparison
Compare DERM & JLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DERM
- JLS
- Stock Information
- Founded
- DERM 2014
- JLS 2009
- Country
- DERM United States
- JLS United States
- Employees
- DERM N/A
- JLS N/A
- Industry
- DERM Biotechnology: Pharmaceutical Preparations
- JLS Investment Managers
- Sector
- DERM Health Care
- JLS Finance
- Exchange
- DERM Nasdaq
- JLS Nasdaq
- Market Cap
- DERM 107.0M
- JLS 99.0M
- IPO Year
- DERM 2021
- JLS N/A
- Fundamental
- Price
- DERM $5.20
- JLS $18.14
- Analyst Decision
- DERM Strong Buy
- JLS
- Analyst Count
- DERM 3
- JLS 0
- Target Price
- DERM $9.50
- JLS N/A
- AVG Volume (30 Days)
- DERM 145.7K
- JLS 26.6K
- Earning Date
- DERM 11-12-2024
- JLS 01-01-0001
- Dividend Yield
- DERM N/A
- JLS 9.33%
- EPS Growth
- DERM N/A
- JLS N/A
- EPS
- DERM N/A
- JLS N/A
- Revenue
- DERM $57,771,000.00
- JLS N/A
- Revenue This Year
- DERM N/A
- JLS N/A
- Revenue Next Year
- DERM $37.38
- JLS N/A
- P/E Ratio
- DERM N/A
- JLS N/A
- Revenue Growth
- DERM N/A
- JLS N/A
- 52 Week Low
- DERM $2.85
- JLS $15.48
- 52 Week High
- DERM $8.11
- JLS $17.97
- Technical
- Relative Strength Index (RSI)
- DERM 43.96
- JLS 47.49
- Support Level
- DERM $5.00
- JLS $17.92
- Resistance Level
- DERM $5.60
- JLS $18.56
- Average True Range (ATR)
- DERM 0.45
- JLS 0.19
- MACD
- DERM -0.04
- JLS -0.00
- Stochastic Oscillator
- DERM 14.98
- JLS 35.61
About DERM Journey Medical Corporation
Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's portfolio includes eight branded and three authorized generic prescription drugs for dermatological conditions that are marketed in the United States. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.
About JLS Nuveen Mortgage and Income Fund
Nuveen Mortgage And Income Fund is a diversified, closed-end management investment company. The Fund invests at least fifty percent of its Managed Assets in MBS, including residential MBS and commercial MBS, and up to fifty percent in non-mortgage related ABS. Its investment objective to generate high current income through opportunistic investments in securitized credit.